Характеристика ожирения

Работа посвящена особенностям ожирения, как болезни, а также сопутствующим ожирению осложнениям сердечно-сосудистой и дыхательной систем.

Введение
1. Ожирение: распространенность, патогенез, осложнения 2
2. Сердечно-сосудистая система при ожирении 21
3. Дыхательная система при ожирении 45
Заключение 52
Литература 53

1. Abergel Е., Tose М., Menard J., Chatellier G. Influence of obesity on diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy. Am J Cardiol, 1996; 77: 739-744.
2. Aim C.W., Kim C.S., Nam J.H., Kim H.J. et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. - Clin Endocrinol (Oxf). 2006, Apr; 64 (4): 444-9.
3. Akashiba Т., Akashiba Т., Kawahara S. et all. Clinical characteristics of obesity- hypoventilation syndrome in Japan: a multi - center study. Internat-Medicine, 2007.
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James PT, Loria CM, Smith Jr SC. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.
5. Alpert M. A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci, 2001, Apr; 321(4): 225-236.
6. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss Am J Cardiol 1997;80:736-740
7. Alwi I., Harun S., Sukmono S., Suwondo P., Oemardi M., Waspadji S., Soegondo S. Left ventricular diastolic dysfunction in obese women. Acta Med Indoncs. 2006, Apr-Jun; 38(2):81-4.
8. Anker S, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study Lancet 2003;361:1077-1083.
9. Barbato J.E., Zuckerbraun B.S., Overbaus M. And all. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and metabolic syndrome. J. Physiol. Heart. Circ. 2005. 289, 228–236
10. Barrett PHR, Watts GF. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effect of nutritional interventions. Curr Opin Lipidol 2003; 14: 61–68.
11. Bercalp B., Cesur V., Corapciogolu D et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol, 1995; 52: 23-26.
12. Betteridge D. J. How does obesity increase cardiovascular risk? In: Obesity and cardiovascular disease. London; 1998, 15-18.
13. Brinkworth G.D., Noakes M., Buckley J.D., Clifton P.M. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. Am Heart J. 2006, Oct; 152(4):693: 1-6.
14. Brochu B. M., Poehlman E. T., Savage P. et al. Coronary risk profiles in men with coronary artery disease: Effects of body composition, fat distribution, age and fitness. Coronary Artery Dis., 2000; 11 (12): 137-144.
15. Busetto L., Strater D., Enzi G., et al. Differential clinical expression of multiple symmetric lipomatosis in men and women. Int J Obes Relat Metab Desord. 2003; Nov; 27 (11): 1419-1422.
16. Caballero A.E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes. Res. 2003. 11, 1278–1289
17. Carroll S, Dudfiled M. What is the relationship between exercise and metabolic abnormalities? Sports Med 2004; 34: 371–418.
18. Cassidy AE, Bielak LF, Zhou Y, Sheedy PF et al. Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation. 2005, Apr 19; 111 (15): 1877-82.
19. Chakko S, Mayor M, Allison, MD, Kessler KM, Materson BJ, Myerburg RJ. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity Am J Cardiol 1991;68:95-98.
20. Chen Y, Rennie D, Cormier YF, Dosman J. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. J. Clin Nutr. 2007, Jan; 85(l):35-9.
21. Chuang S.Y., Chou P., Hsu P.F., Cheng H.M., Tsai S.T., Lin I.F., Chen C.H. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens. 2006, Aug; 19 (8):788-95.
22. Colditz G. A., Willeett W., Rotnitzky A., Manson J. Weight gain as risk factor for clinical liabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
23. Collins L.C., Hoberty P.D., Waker J.F., Flecher E.C., Peiris A.N. The effect of body fat distribution on the pulmonary function tests. Chest, 1995; 107: 1298-1303.
24. Davy K., Hall J. Obesity and hypertension: two epidemics or one? Am J. Physiol. Regul Integr Comp Physiol. 2004,-286, p.803-813.
25. Dc Bacquer D., De Bacquer G., Cokkinos D. et al. Overweight and obesity in patients with established coronary heart disease: Are we meeting the challenge? Eur. Heart J., 2004; 25: 121¬128.
26. De Divitus, Fazio S., Petitto M., Maddalena G. et al. Obesity and cardiac function.